These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 9092797

  • 1. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, deVere White RW, Pretlow TG, Harris SE, Wilson EM, Mohler JL, French FS.
    Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
    [Abstract] [Full Text] [Related]

  • 2. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T, Bertolini R, Nichols SE, Setoud R, Frey FJ, Baker ME, Frey BM.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1651-62. PubMed ID: 21907706
    [Abstract] [Full Text] [Related]

  • 3. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z, Hobisch A, Cronauer MV, Cato AC, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H.
    Mol Endocrinol; 1993 Dec 01; 7(12):1541-50. PubMed ID: 8145761
    [Abstract] [Full Text] [Related]

  • 4. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Fenton MA, Shuster TD, Fertig AM, Taplin ME, Kolvenbag G, Bubley GJ, Balk SP.
    Clin Cancer Res; 1997 Aug 01; 3(8):1383-8. PubMed ID: 9815822
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line.
    Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L, Lee LF, Pretlow TG, Kung HJ.
    Cancer Res; 2002 Nov 15; 62(22):6606-14. PubMed ID: 12438256
    [Abstract] [Full Text] [Related]

  • 6. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
    Attardi BJ, Burgenson J, Hild SA, Reel JR.
    Mol Cell Endocrinol; 2004 Jul 30; 222(1-2):121-32. PubMed ID: 15249132
    [Abstract] [Full Text] [Related]

  • 7. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M.
    Cancer Res; 2003 Jan 01; 63(1):149-53. PubMed ID: 12517791
    [Abstract] [Full Text] [Related]

  • 8. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.
    Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD.
    Mol Endocrinol; 2001 Jan 01; 15(1):46-56. PubMed ID: 11145738
    [Abstract] [Full Text] [Related]

  • 9. Suppression of mutant androgen receptors by flutamide.
    Ishioka J, Hara S, Isaacs JT, Tomura A, Nishikawa K, Kageyama Y.
    Int J Urol; 2009 May 01; 16(5):516-21. PubMed ID: 19389135
    [Abstract] [Full Text] [Related]

  • 10. Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens.
    Zhou J, Liu B, Geng G, Wu JH.
    Proteins; 2010 Feb 15; 78(3):623-37. PubMed ID: 19787772
    [Abstract] [Full Text] [Related]

  • 11. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K, Hara N, Nishiyama T, Tasaki M, Ishizaki F, Tomita Y.
    BMC Cancer; 2016 May 25; 16():332. PubMed ID: 27225190
    [Abstract] [Full Text] [Related]

  • 12. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS, Marks BD, Gowda K, Kupcho KR, Ervin KM, De Rosier T, Qadir N, Eliason HC, Riddle SM, Shekhani MS.
    Biochemistry; 2007 Jan 23; 46(3):683-95. PubMed ID: 17223690
    [Abstract] [Full Text] [Related]

  • 13. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
    Warriar N, Pagé N, Koutsilieris M, Govindan MV.
    Prostate; 1994 Apr 23; 24(4):176-86. PubMed ID: 8146066
    [Abstract] [Full Text] [Related]

  • 14. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H.
    Cancer Detect Prev; 1996 Apr 23; 20(1):68-75. PubMed ID: 8907206
    [Abstract] [Full Text] [Related]

  • 15. 3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity.
    Miyamoto H, Marwah P, Marwah A, Lardy H, Chang C.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4440-4. PubMed ID: 12672951
    [Abstract] [Full Text] [Related]

  • 16. Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.
    Masiello D, Chen SY, Xu Y, Verhoeven MC, Choi E, Hollenberg AN, Balk SP.
    Mol Endocrinol; 2004 Oct 15; 18(10):2388-401. PubMed ID: 15256534
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):21-8. PubMed ID: 10334909
    [Abstract] [Full Text] [Related]

  • 18. Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer.
    Steketee K, Timmerman L, Ziel-van der Made AC, Doesburg P, Brinkmann AO, Trapman J.
    Int J Cancer; 2002 Jul 20; 100(3):309-17. PubMed ID: 12115546
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide.
    Wang C, Young WJ, Chang C.
    Endocrine; 2000 Feb 20; 12(1):69-76. PubMed ID: 10855693
    [Abstract] [Full Text] [Related]

  • 20. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
    Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.